Sort   by:  
 Page size 
UnknownConstruction and validation of renal cell carcinoma tumor cell differentiation-related prognostic classification (RCC-TCDC): an integrated bioinformatic analysis and clinical study.
Not available
S-EPMC12010653 | biostudies-literature
UnknownUnveiling the unique role of TSPAN7 across tumors: a pan-cancer study incorporating retrospective clinical research and bioinformatic analysis.
Not available
S-EPMC11340126 | biostudies-literature
UnknownEvolution of the "Internet Plus Health Care" Mode Enabled by Artificial Intelligence: Development and Application of an Outpatient Triage System.
Not available
S-EPMC11561436 | biostudies-literature
UnknownEfficacy of three-dimensionally integrated exercise for scoliosis in patients with adolescent idiopathic scoliosis: study protocol for a randomized controlled trial.
Not available
S-EPMC6131734 | biostudies-literature
UnknownClinical and genetic characteristics of 42 Chinese paediatric patients with X-linked adrenal hypoplasia congenita.
Not available
S-EPMC10214642 | biostudies-literature
ProteomicsHippocampal proteomic alteration in triple transgenic mouse model of Alzheimer’s disease: insights into the role of PINK 1 proteins in donepezil treatment Hippocampal proteomic alteration in triple transgenic mouse model of Alzheimer’s disease: insights into the role of PINK 1 proteins in donepezil treatment
Donepezil, an acetylcholinesterase (AChE) inhibitor, was approved by FDA for the symptomatic therapies of patients with Alzheimer’s disease (AD) in 1996. Although donepezil have been regarded as the standard and first-line treatment for AD, the capacity of such drugs to alter the underlying disease ...
ORGANISM(S): Mus musculus (Mouse) 
2018-12-03 | PXD010604 | Pride
Alzheimer’s disease (ad) Amyloid beta (aβ) Donepezil Proteomics Pink1 
UnknownDouble-blind, placebo-controlled randomised clinical trial to evaluate the effect of ASPIRIN discontinuation after left atrial appendage occlusion in atrial fibrillation: protocol of the ASPIRIN LAAO trial.
Not available
S-EPMC7970210 | biostudies-literature
ProteomicsEvaluation of therapeutic effects of tetramethylpyrazine nitrone in Alzheimer’s disease mouse model and proteomics analysis
The pathophysiology of Alzheimer’s disease (AD) is multifactorial with characteristic extracellular accumulation of amyloid-beta (Aβ) and intraneuronal aggregation of hyperphosphorylated tau in the brain. Development of disease-modifying treatment for AD has been challenging. Recent studies suggest ...
ORGANISM(S): Mus musculus (Mouse) 
2023-05-10 | PXD039514 | Pride
Amyloid beta Alzheimer’s disease Pink1. Tetramethylpyrazine nitrone Proteomic analysis 
ProteomicsProteomic profiling of hippocampus and cerebral cortex in triple-transgenic mouse model of Alzheimer’s disease: Alterations with memantine treatment, part 2
INTRODUCTION Alzheimer’s disease (AD) is an advanced neurodegenerative disorder characterized by progressive impairment in both memory loss and cognitive capacities, which resulting in severe dementia [1]. The pathogenesis of AD is complicated and poorly understood. According to the World Alzheimer ...
ORGANISM(S): Mus musculus (Mouse) 
2019-11-12 | PXD012110 | Pride
Memantine (mem) Alzheimer’s disease (ad) Proteomics 
UnknownAn X chromosome-wide association analysis identifies variants in GPR174 as a risk factor for Graves' disease.
Not available
S-EPMC3686253 | biostudies-literature
Sort   by:  
 Page size